Brought to you by 
Watson gets rights to Population Council's contraceptive ring
01 Apr 2010
Executive Summary
Watson Pharmaceuticals (women's health products and urology drugs) has received exclusive US, Canadian, and Mexican rights to the Population Council's (non-profit research organization focused on reproductive health across the globe) Phase III contraceptive vaginal ring.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Watson gets rights to Population Council's contraceptive ring
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice